About Us

Luye Pharma Group (02186.HK), a member of Luye Life Sciences Group, is an international pharmaceutical company dedicated to the R&D, manufacturing and sale of innovative medications.

On The Road

Marketing Authorization Application for Luye Pharma's Innovative Anticancer Formulation Goserelin Microspheres Accepted in China

News

Luye Pharma Group today announced that the marketing authorization application for Goserelin Acetate Extended-release Microspheres for Injection (LY01005), an innovative formulation for the treatment of prostate cancer, has been accepted by ...

December 29,2021

Luye Pharma Releases Top-Line Results from a Phase II Clinical Trial of Its New Antidepressant Ansofaxine Hydrochloride Extended-Release Tablets

- Showing a comprehensive antidepressant efficacy and a good safety profile without an impact on sexual function - Luye Pharma Group today released the encouraging top-line results from a Phase II clinical trial of its new antidepressant, ...

December 23,2021

Read More

Investors

Employee Stories

Upholding the philosophy of “Employee Development”,
Luye Pharma regards employees as the most valuable resources of the company